Saturday, 25th November 45th Annual ARA NSW-ACT Branch Meeting 2023

INVITED SPEAKERS: Joanna Tieu and Daniel Sumpton

• Welcome and introduction to the new program - Anthony Sammel
• To characterise cases of de novo check point inhibitor (CPI) induced polyarthritis in cancer patients treated at a tertiary referral centre - Jang Yoon
• Updates in spondyloarthropathies - Daniel Sumpton
• ANCA associated vasculitis – best practice care in 2023 - Joanna Tieu

Q&A with Joanna Tieu and Daniel Sumpton. 

• Myositis - tailoring therapy to phenotype - Matthew JS Parker
• PET/CT in the assessment of large vessel vasculitis - Eva Alina Wegner

Presenting Co-Author: Tony Sammel

11:10am Panel - Dr Joanna Tieu, Dr Eva Wegner, Dr Tony Sammel
Vasculitis BYO cases for expert panel review (CPD category 2)

• Prevalence of periodontoid calcification in patients presenting to ED with acute neck pain - Helen H Au
• Radiofrequency Echographic Multi Spectrometry (REMS) for the measurement of bone density at the lumbar spine and hip – a “real-life” Australian validation study - Patrick J Baquir
• Vaccination rates in patients with autoimmune rheumatic diseases at Concord Hospital Outpatient Clinics - Dani Chandrasoma
• Co-designed education video for the management of gout in an outpatient setting: A before-and-after study evaluating patient activation and gout knowledge - Armando Faigl
• Review the Spectrum of Clinical Manifestations in Antisynthetase Antibody Positive Patients. - Danny Kasto
• Implementing an Interprofessional Medication Adherence Program for People with Gout: A Pilot Feasibility Study - Brian Liang
• Association of hip pain exacerbations with air pollutants - Xiaoqian Liu
• Ion Channels in health and disease - Nicholas Manolios
• Non-Antigenic Modulation of Antigen Receptor (TCR) C-FG Loop Modulates Signalling: Implications of External Factors Influencing T-Cell Responses   - Nicholas Manolios
• Person-centred care interventions to improve healthcare delivery in rheumatoid arthritis: A consumer co-designed systematic review of randomised controlled trials - Dennis Neuen
• Rheumatic immune-related adverse effects of checkpoint inhibitors - Arupam AR Raman
• Adherence to latent infection screening recommendations for Rheumatology outpatients on immunosuppressive therapies, including Strongyloides stercoralis testing - Gary Xu